Risk Matters: Tariff Risks and Opportunities for Pharma Manufacturers
University of Maryland, Robert H. Smith School of BusinessRisk management expert Clifford Rossi warns that pharma tariffs could disrupt supply chains, raise costs, and pressure manufacturers, especially generics. Adopting continuous manufacturing offers efficiency gains, balancing risk mitigation with strategic investment.